跳至主要内容
临床试验/NCT01005082
NCT01005082已完成2 期

Calcium Nephrolithiasis: Clinical Characteristics and Nutritional Determinants

University of Parma2 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2005年1月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
210
试验地点
2
主要终点
Normalization of urinary calcium levels

研究概览

简要总结

Randomized clinical trial comparing water therapy plus low-salt diet to water therapy alone in patients affected by idiopathic calcium nephrolithiasis.

Treatment duration: three months Primary end-point: correction of hypercalciuria Main inclusion criteria: calcium stone formers with idiopathic hypercalciuria, with at least one stone expelled and analyzed by infrared spectrophotometry; presence of hypercalciuria (>300 mg/day in males and >200 mg/day in females); 18-65 years.

Main exclusion criteria: primary hyperparathyroidism, primary hyperoxaluria, enteric hyperoxaluria, bowel resection, inflammatory bowel disease, renal tubular acidosis, sarcoidosis, sponge kidney, hyperthyroidism, use of hypercalciuric drugs such as Vitamin D, acetazolamide, anti-epileptic drugs

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Normalization of urinary calcium levels

次要结局

  • Change in urinary stone risk factors (e.g. urinary calcium, oxalate and sodium excretion); blood pressure reduction

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验